59843-69-5 Usage
General Description
3-(3-Chlorophenyl)-1H-pyrazole, also known as CPP, is a chemical compound with a molecular formula C9H7ClN2. It is a pyrazole derivative that is commonly used in scientific research as a pharmaceutical intermediate and reagent. CPP has been studied for its potential use in the development of new drugs for the treatment of various medical conditions, including neurological disorders, inflammation, and cancer. It has also been investigated for its role in modulating the endocannabinoid system and its potential as a ligand for cannabinoid receptors. Additionally, CPP has shown promise as a potential anticonvulsant and analgesic agent in preclinical studies. However, further research is needed to fully understand its pharmacological properties and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 59843-69-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,8,4 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 59843-69:
(7*5)+(6*9)+(5*8)+(4*4)+(3*3)+(2*6)+(1*9)=175
175 % 10 = 5
So 59843-69-5 is a valid CAS Registry Number.
59843-69-5Relevant articles and documents
SUBSTITUTED PYRAZOLO-PYRIMIDINES AND USES THEREOF
-
Paragraph 0287; 0290; 0291, (2021/07/24)
The present disclosure provides compounds that are inhibitors of PIKfyve kinases useful for the treatment of neurological diseases treatable by inhibition of PIKfyve. Also provided are pharmaceutical compositions containing such compounds, and methods of
QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS
-
Page/Page column 76, (2008/12/06)
The present invention relates to novel quinolones of Formula I that inhibit inducible NOS synthase together with methods of synthesizing and using the compounds including methods for inhibiting or modulating nitric oxide synthesis and/or lowering nitric oxide levels in a patient by administering the compounds for the treatment of disease.
